Article
The shared epitope is a marker of severity associated with selection for, but not with response to, infliximab in a large rheumatoid arthritis population.
Annals of the rheumatic diseases - 1 Mar 2006
Marotte H, Pallot-Prades B, Grange L, Tebib J, Gaudin P, Alexandre C, Blond J L, Cazalis M A, Mougin B, Miossec P
Abstract excerpt
OBJECTIVE: To determine whether joint destruction, indication for, and response to infliximab in rheumatoid arthritis are associated with the shared epitope (SE) or selected cytokine gene polymorphisms (interleukin (IL) 1B, IL1-RN, and tumour necrosis alpha). METHODS: In a large rheumatoid arthritis population of 930 patients from the same area (Rhône-Alpes, France), patients with (n = 198) or without infliximab...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
